Voyager Therapeutics
Social media
Voyager Therapeutics Logo
About Voyager Therapeutics
Voyager Therapeutics Inc is a clinical-stage biotechnology company focused on developing gene therapies and genetic medicines for severe neurological diseases, including Alzheimer's disease, ALS, Parkinson's disease, Friedreich's ataxia, and Huntington's disease. The company utilizes its TRACER AAV capsid discovery platform to advance novel therapies that cross the blood-brain barrier. Voyager's pipeline includes both clinical and preclinical programs targeting neurodegenerative disorders. Founded in 2013 and headquartered in Lexington, Massachusetts, the company collaborates with leading pharmaceutical firms to advance its research and development.
Address
75 Hayden Avenue,
Lexington, 02421
United States
Year founded
2013
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
